Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-106294

Anacor Pharmaceuticals, Inc. · ANAC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Vincent P Ippolito
Officer — EVP & Chief Commercial Officer
Period of report
Mar 2, 2016
Accepted (ET)
Mar 4, 2016 · 9:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411158

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Mar 2, 2016S1,600$62.229D75,385D
Common StockF3Mar 2, 2016S1,875$63.5553D73,510D
Common StockF4Mar 2, 2016S3,696$64.2176D69,814D
Common StockF5Mar 2, 2016S1,829$64.8834D67,985D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses